FEATURES OF DIAGNOSTICS OF BERNARD-SOULIER SYNDROME

被引:0
作者
Kumskova, M. A. [1 ]
Yastrubinetskayc, O., I [1 ]
Likhachyova, E. A. [1 ]
Vasiliev, S. A. [1 ]
Dvirnyk, V. N. [1 ]
Konyashina, N., I [1 ]
Al-Radi, L. S. [1 ]
Moiseeva, T. N. [1 ]
Zozulya, N., I [1 ]
机构
[1] Natl Res Ctr Hematol, Moscow 125167, Russia
来源
GEMATOLOGIYA I TRANSFUZIOLOGIYA | 2016年 / 61卷 / 04期
关键词
Bernard Soulier syndrome; platelets; macrothrombocytopenia; inherited platelet disorders; platelet function; coagulopathy; hemostasis; PLATELET DISORDERS; GPIB-BETA;
D O I
10.18821/0234-5730-2016-61-4-217-221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bernard Soulier syndrome (BSS) is the rare platelet disorder. It is caused by the deficiency or defect of the glycoprotein (GP) lb-IX-V complex on the surface of platelets - the main receptor for von Willebrand factor (vWF). Binding of vWF with GP lb-IX-V complex initiates primary hemostasis and provides platelets adhesion at the site of the injured blood vessel. Dissociation of plasma, vascular and thrombocytic hemostasis gives rise to the development of the microcirculatory or mixed hemorrhagic syndrome. The typical features of such types are considered in the clinical case of the BSS female patient. Diagnostic algorithm for BSS includes the evaluation of functional properties, morphology and biochemical characteristics of platelets with the compulsory use of flow cytometry, allowing to reveal the deficiency of GP lb-IX-V complex on the surface of platelets.
引用
收藏
页码:217 / 221
页数:5
相关论文
共 25 条
[1]   Bernard-Soulier Syndrome: An Update [J].
Andrews, Robert K. ;
Berndt, Michael C. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (06) :656-662
[2]  
Aziz KA, 2005, SAUDI MED J, V26, P1095
[3]  
BERNARD J, 1948, Sem Hop, V24, P3217
[4]   Structural Basis of Regulation of von Willebrand Factor Binding to Glycoprotein Ib [J].
Blenner, Mark A. ;
Dong, Xianchi ;
Springer, Timothy A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (09) :5565-5579
[5]   A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO [J].
Bolton-Maggs, Paula H. B. ;
Chalmers, Elizabeth A. ;
Collins, Peter W. ;
Harrison, Paul ;
Kitchen, Stephen ;
Liesner, Ri J. ;
Minford, Adrian ;
Mumford, Andrew D. ;
Parapia, Liakat A. ;
Perry, David J. ;
Watson, Steve P. ;
Wilde, Jonathan T. ;
Williams, Michael D. .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (05) :603-633
[6]  
Bussel James B., 2000, Hematology Am Soc Hematol Educ Program, P222
[7]  
Daskalakis M, 2014, CYTOM PART B-CLIN CY, V86, P397, DOI [10.1002/cyto.b.21157, 10.1002/cytob.21157]
[8]  
Demina I.A., 2015, HEMATOLOGY TRANSFUSI, V60, P41
[9]  
Demina I.A., 2015, RUSSIAN J CHILDREN H, V2, P54
[10]   The use of recombinant activated factor VII in platelet disorders: a critical review of the literature [J].
Franchini, Massimo .
BLOOD TRANSFUSION, 2009, 7 (01) :24-28